Mikolaj Nalecz

Mikolaj Nalecz serves as CEO at Cosmedica. Cosmedica operates in the pharmaceuticals sector with approximately 240.0 employees. The company is headquartered in Warsaw, Masovian Voivodeship.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 1,088 executive contacts are available in Masovian Voivodeship.
• • Our database includes 201,465 c suite-level executives.

Gmail Google Apps Google Font API Google Tag Manager Bootstrap Framework Mobile Friendly reCAPTCHA YouTube AI

pharmaceutical manufacturing pharmacy patient care healthcare dermocosmetics medical marijuana pharmaceutical care online education e-learning training programs internship blood pressure measurement diagnostics vaccination recruitment health benefits personal development internal training patient well-being pharmaceutical internships modern pharmacy otc medications clinical consultations patient education community pharmacies pharmaceutical knowledge workplace benefits customer service apothecary health & wellness programs pharmacist collaboration competitive salary work-life balance professional growth continuous improvement teamwork mentorship effective communication pharmaceutical recipes eye prescription community engagement networking health promotion recruitment opportunities career development pharmacotherapy knowledge sharing interprofessional collaboration supportive workplace policy compliance job security pharmaceuticals medical health care health wellness & fitness hospital & health care internet information technology & services computer software education management education mentoring

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Mikolaj Nalecz in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Cosmedica.

Mikolaj Nalecz's Position in the MessageCEO Database

• •Mikolaj Nalecz is 1 of 1 verified executive contact we track at Cosmedica.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •1,083 verified executive contacts in Masovian Voivodeship are in the database.
• •16 verified contacts work at pharmaceuticals companies in the 240.0 employee range (same size as Cosmedica).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Mikolaj Nalecz directly?

Mikolaj Nalecz's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Cosmedica. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Mikolaj Nalecz work for?

Mikolaj Nalecz is CEO at Cosmedica, a company in the pharmaceuticals sector with 240.0 employees. The company is based in Warsaw, Masovian Voivodeship.

Can I pitch or sell to Mikolaj Nalecz?

As CEO at Cosmedica, Mikolaj Nalecz is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Mikolaj Nalecz directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Mikolaj Nalecz in?

Mikolaj Nalecz works in the pharmaceuticals industry as CEO at Cosmedica. MessageCEO provides verified contact information for executives across all major industries.

Is Mikolaj Nalecz's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mikolaj Nalecz's profile is kept up-to-date with the latest available information.

Last updated: October 7, 2026